117 days ago
In February of this year Guild Advisory “parted company” with what was then Wildcat Petroleum , now Wildcat Gold (WCAT) as its Main Market listed advisor. Wildcat could not afford to pay the fees so declined to renew the annual contract. Guild let it be known that it was not devastated, it had read all the exposes of the lies, the pumping and other shenanigans on this website, it knew Wildcat was a wrong un. Today…
166 days ago
There are those "experts" who will still tell you that all is well at Skinbiotherapeutics (SBTX), we know the full extent of the fraud and that we will get results in April confirming we will soon enter the Croda sunlit uplands. Are the "experts" who used to eat out of the hand of Ashman really sure? They may be right, thus time, but...
190 days ago
Any suggestion from the denialists that Skinbiotherapeutics (SBTX) might have over egged the extent of the crimes of disgraced prolific liar and fraudster Stuart Ashman and that there might be a kiss and make up are today put to bed with news that Rachel Parsonage has been appointed as interim CEO. She appears to have a cracking CV but..
197 days ago
How accurate are the Amazon reviews for the Skinbiotherapeutics (SBTX) psoriasis product which smells like dog fart and tastes worse? It is a valid question as it may have some bearing on renewal rates and thus whether thus business can ever make a profit on an all in costs basis. It has not to date. And has Skins conveyed that message accurately to investors?
199 days ago
On October 6 2025 Skinbiotherapeutics (SBTX) announced that 195 Superdrug stores would be stocking its acne and psoriasis products “imminently” as part of a two year exclusive deal set to expire in June 2027. All well and good.
229 days ago
In an interview with a rodent Stuart Ashman of Skinbiotherapeutics (SBTX) branded me a “prolific liar” without actually evidencing one single lie. Anyhow on the question of prolific liars…
265 days ago
Bearded Geordie poltroon Stuart Ashman says without citing one actual example that I am a “prolific liar.” The overpaid and under-delivering CEO of Skinbiotherapeutics (SBTX) thinks that he always tells the truth. Let’s rewind to June 16th when shareholders were 10% diluted in a £4.2 million placing.
270 days ago
Unable to sleep last night I checked out the Superdrug website and to have a look at the Skinbiotherapeutics (SBTX) acne and psoriasis products.
Acne sure is a crowded field, Superdrug sells 376 products including the one from Skins.
308 days ago
Our in house bien pensant PL appears to have stumbled on forecasts from credible tier 1 brokers for how much revenue Croda (CRDA) will make from sales of the Skinbiotherapeutics (SBTX) product Zenakine. The source of this is, PL says, AI so it may be hogwash but it, perhaps, raises two critical points.
326 days ago
As you can see below the Skinbiotherapeutics (SBTX) is, several weeks late, now for sale at Superdrug. Whether the returns justify the 10% dilution of the June placing, supposedly to fund this rollout, is uncertain. I doubt it . But at least here should now be sales and cash coming in.
350 days ago
I am not saying that Stuart Ashman has goofed operationally. But in terms of being transparent with investors he really is clueless and I say that in a spirit of Christian compassion.
363 days ago
The pretext for the June 16 placing by Skinbiotherapeutics (SBTX) conducted before the company ‘fessed that it was going to miss June 30 revenue forecasts by a country mile, was that cash was needed for a new product launch with Superdrug.
398 days ago
I do not disagree with a word in this email. I have also made my views clear to the regulators. It is abundantly clear that forecasts out there are wrong and that the company and ts house broker knows all about it and is happy to see a false market continue. The reader writes:
413 days ago
I am not sure what the prize will be but there will be one. Stuart Ashman has said that the research from analyst “Kevin” Keegan at house broker Singer contain errors and we all know the sales numbers are just plain wrong. I will explain my forecasts for the years ending June 30 2025 and 2026 below. The contest is to give your 2026 forecast and as a tie breaker 2025.
426 days ago
The Singer’s initiation note on its corporate client Skinbotherapeutics(SBTX) is a curious piece of fish. For staters Singer’s makes it clear that it will not, under any circumstances, be made available to private investors it is for II’s and City HNWIs only. This is pointless.
449 days ago
Today Skinbiotherapeutics (SBTX) has announced that Superdrug is to sell its acne and psoriasis products. That is the good news. But to fund the rollout it has diluted us all by another 10% with a placing. On 16 April CEO Stuart Ashman recorded an Investor Meet video. Here are two clips. Please can anyone explain why he is not now exposed as a 100% lying scumbag?
